Arcturus, also known as XBB.1.16, has also attracted attention after reports linking it to what has been a rare COVID-19 symptom: pink eye.

Arcturus, a more infectious COVID subvariant, grows in L.A. County, seen in sewage Some commuters wear masks on a Metro train in Los Angeles on March 29.

Health chiefs first detected 'Arcturus', a highly infectious spin-off of Omicron, in New York in late January. But it has since spread to 26 more states and triggered 235 cases, with hotspots ...

Detections of a new subvariant of COVID-19 are increasing in the US, and it's now responsible for nearly 10% of all coronavirus cases, according to the Centers for Disease Control and Prevention.

Arcturus has been reported in several states in the US, including California, Washington, New Jersey, New York, Virginia and Texas, New York Post reported. “It’s been in circulation for a few ...

The World Health Organization has elevated the fast-growing Omicron sublineage XBB.1.16 as a new variant of interest, and says it is outcompeting the previously dominant XBB.1.5 in many regions.

XBB.1.16, referred to as “ arcturus,” was responsible for 9.6% of new infections this week, according to CDC estimates. That’s up from nearly 6% of cases the week before and about 3% two ...

In the U.S,, the XBB.1.16 accounted for an estimated 7.2% of all Covid-19 samples from April 9 to April 15, according to the Centers for Disease Control and Prevention (CDC). That’s up from 3.9% ...

Arcturus — one of more than 600 Omicron subvariants — was first detected in January. It’s being monitored by the World Health Organization, with some officials noting it had some mutations ...

XBB.1.16, dubbed “Arcturus” by variant trackers, is fueling a new surge of cases in India, at a time when reported cases are down in much of the rest of the world. The country’s health ...

Arcturus Therapeutics ARCT 0.0% announced this morning that it has initiated dosing of its Covid-19 vaccine candidate—LUNAR COV-19, (ARCT-021)—in a Phase 1/2 study in collaboration with Duke ...